Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): A randomized, double-blinded, multicenter, Phase 2 study

20260 citationsJournal Article

Authors

Kinevant Sciences GmbH.

Good health and well-being

Published in: European Respiratory Journal

Field-Weighted Citation Impact: 0.00